Package 50090-3539-0

{"route": ["ORAL"], "spl_id": "ea19ae9c-7263-48a1-88d5-e29ec91c6792", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["ef4e97a7-cd18-47a9-a016-2eca5481a87e"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-3539-0)", "package_ndc": "50090-3539-0", "marketing_start_date": "20180815"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-3539-1)", "package_ndc": "50090-3539-1", "marketing_start_date": "20180815"}], "brand_name": "Phenytoin Sodium", "product_id": "50090-3539_ea19ae9c-7263-48a1-88d5-e29ec91c6792", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-3539", "generic_name": "Phenytoin Sodium", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20060905", "listing_expiration_date": "20261231"}